학술논문
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
Document Type
Article
Author
Lin, C.-C.; Garralda, E.; Schöffski, P.; Hong, D.S.; Siu, L.L.; Martin, M.; Maur, M.; Hui, R.; Soo, R.A.; Chiu, J.; Zhang, T.; Ma, B.; Kyi, C.; Tan, D.S.W.; Cassier, P.A.; Sarantopoulos, J.; Weickhardt, A.; Carvajal, R.D.; Spratlin, J.; Esaki, T.; Rolland, F.; Akerley, W.; Deschler-Baier, B.; Rispoli, L.; Gusenleitner, D.; Kwak, E.L.; Askoxylakis, V.; Samant, T.S.; Chowdhury, N.R.; De Braud, F.
Source
In: OncoImmunology . (OncoImmunology, 2024, 13(1))
Subject
Language
English
ISSN
2162402X
21624011
21624011